جست‌وجوی استاد و پژوهشگر

Philip Burchamمشاهده پروفایل

دانشیار

• Toxicology
• Pharmacology
• Oxidative Stress
• +۵ مورد دیگر

Philip Burcham is an Associate Professor with joint appointments in the School of Biomedical Sciences and School of Allied Health at The University of Western Australia. He holds expertise in pharmacology and toxicology, focusing on novel therapeutic strategies against oxidant-induced cell damage. His research emphasizes acrolein's role in diseases like neurotrauma and pulmonary disorders. He contributed significantly to UWA's curriculum, including the 'Drugs that Changed the World' course. Educational background includes a PhD in pharmacology from 1990, postdoctoral training at Vanderbilt University's Center for Molecular Toxicology, and prior roles at the University of Adelaide. His work bridges academia and practical applications, including drug repurposing and carbonyl scavenger development. Research interests include protein damage by reactive chemicals, toxicological consequences of drug metabolism, and lung injury from smoke. Key projects involve collaborations on acrolein toxicity mechanisms and pharmaceutical innovation. He has authored over 40 publications, including a textbook on toxicology. Grants include funding from NHMRC, ARC, and industry partnerships, supporting studies on acrolein, lung injury, and drug delivery. His lab explores ex vivo perfusion systems and molecular mechanisms of toxin-induced damage.

David J Durganمشاهده پروفایل

استادیار

• Gut Microbiota
• Cardiovascular Disease
• Hypertension
• +۳ مورد دیگر

David J Durgan, Ph.D., is an Assistant Professor at Baylor College of Medicine's Department of Integrative Physiology & Anesthesiology. His research focuses on the role of gut microbiota in cardiovascular diseases, particularly hypertension and stroke, using rodent models and omics approaches. He holds a PhD from the University of Alabama at Birmingham (2011), an MS from California Polytechnic State University (2005), and a BS from the University of Wyoming (2000). Research interests include mechanisms linking gut microbiota to blood pressure regulation, neurovascular dysfunction in obstructive sleep apnea, and microbiome influences on cerebrovascular health. Key findings include microbiota restructuring via intermittent fasting lowering blood pressure and microbiome contributions to blood-brain barrier disruption in hypertensive rats. Notable publications highlight microbiota-mediated pathways in hypertension, stroke pathology, and age-related cognitive decline. His work integrates multi-omics and in vitro assays to dissect host-microbiota communication. Laboratory facilities include BCM 307/315B.

Abbie Chapmanمشاهده پروفایل

استادیار

• Neurovascular Biology
• Dementia
• Hippocampal Vasculature
• +۳ مورد دیگر

Abbie Chapman is an Assistant Professor in the Department of Psychology at Binghamton University (SUNY). Her research focuses on understanding vascular contributions to cognitive impairment and dementia, particularly in the hippocampus. She investigates how age, hypertension, and menopause affect hippocampal neurovascular function, aiming to develop strategies to protect against hypoxic/ischemic injury and maintain neurocognitive health. Chapman’s lab employs advanced techniques such as pressure myography, laser Doppler flowmetry, and electrophysiology to study hemodynamic and cognitive consequences of vascular dysfunction. She emphasizes sex differences in hippocampal vulnerability, especially post-menopause, and explores interventions like apocynin treatment to mitigate cerebrovascular damage. Her educational background includes a PhD from the University of Vermont and a BS from the University of Maine at Orono. She actively mentors students, including Risa Kalish and Brian Deng, and collaborates across disciplines to address aging-related dementias and stroke mechanisms. Recent work highlights the role of oxidative stress and neuroinflammation in cognitive decline, with implications for preeclampsia and hypertension. Chapman’s achievements include mentoring award-winning undergraduates and advancing public awareness through media features like Woman’s World Magazine.

• Neurochemistry
• Auditory Neuroscience
• Environmental Toxicology
• +۳ مورد دیگر

Aaron Apawu is an Associate Professor in the Department of Chemistry and Biochemistry at the University of Northern Colorado, within the College of Natural and Health Sciences. His research focuses on the neurochemical impacts of environmental contaminants (e.g., noise, solvents) on brain chemistry, with emphasis on dopamine signaling in auditory pathways and inhalant abuse mechanisms. He employs electrochemical methods, imaging, and molecular assays in rodent models to study these phenomena. Education: Post-Doc in Auditory Science/Anatomy & Cell Biology: Wayne State University School of Medicine Ph.D. in Analytical Chemistry: Wayne State University M.S. in Analytical Chemistry: East Tennessee State University B.S. in Chemistry: University of Cape Coast, Ghana Research Interests: Neurochemical effects of inhalant abuse on dopamine pathways Auditory system dopamine/serotonin roles and noise trauma impacts Synergistic effects of chemical/noise exposures in occupational settings His work contributes to understanding inhalant addiction mechanisms, audiotoxicity, and developing neuroprotective strategies. Ongoing efforts include MRI-compatible nanoparticle delivery systems for tinnitus treatment and exploring oxidative stress in hearing loss.

Jeannie Chinمشاهده پروفایل

استاد

• Alzheimer's Disease
• Epilepsy
• Neurodegenerative Disorders
• +۴ مورد دیگر

Jeannie Chin, Ph.D., is a Professor in the Department of Neuroscience at Baylor College of Medicine. She holds a BA/BS in Zoology/Biology from the University of Texas, Austin, a PhD in Neuroscience from the University of Texas Graduate School of Biomedical Sciences, and completed postdoctoral training at the Gladstone Institute of Neurological Disease and UCSF. Her research focuses on understanding cellular and network mechanisms underlying cognitive impairments in Alzheimer’s disease, epilepsy, and other neurological disorders, combining biochemistry, molecular biology, in vivo physiology, and behavioral paradigms. Key interests include activity-dependent epigenetic regulation, neural stem cell dynamics, and corticothalamic network dysfunction. Recent work highlights therapeutic strategies targeting ΔFosB, Tiam1, and thalamic activity to improve cognition and reduce disease progression. Dr. Chin’s lab is part of the Memory & Brain Research Center at BCM, and she serves as Deputy Editor for a scientific journal. Education: Postdoctoral Training: Gladstone Institute of Neurological Disease and UCSF (2007) PhD: University of Texas Graduate School of Biomedical Sciences (Neuroscience, 2001) BA/BS: University of Texas, Austin (Zoology/Biology, 1994) Research interests emphasize linking cellular alterations to memory deficits in mouse models of AD using EEG, biochemical assays, and viral gene expression. Her lab investigates molecular mechanisms of cognitive dysfunction and identifies therapeutic entry points. Notable contributions include studies on PTEN mutations, Aβ-induced neuronal activity, and corticothalamic network dysfunction. Awards include the Deputy Editor role, reflecting her leadership in neuroscience publishing. Advising includes graduate students (Joseph Campbell, Pei-Yun Chuang, Yoshitaka Furuta) and MD/PhD candidates (Corey St. Romain). Collaborative grants focus on Alzheimer’s and epilepsy, with ongoing work on molecular MRI probes and interventional strategies to restore cognition. The Chin Lab’s interdisciplinary approach bridges basic science and clinical applications, aiming to translate discoveries into therapies for neurological diseases.

Nora Vanegas Arroyaveمشاهده پروفایل

دانشیار

• Neurology
• Parkinson's Disease
• Neuromodulation
• +۷ مورد دیگر

Nora Vanegas Arroyave, M.D., is an Associate Professor of Neurology and Director of Neuromodulation Research at Baylor College of Medicine. She specializes in neuromodulation therapies for neuropsychiatric conditions, particularly Parkinson’s Disease, dystonia, essential tremor, and depression. Her work integrates clinical care, research, and industry-sponsored trials to advance neurodegenerative disease treatment. She completed an NIH fellowship in neuroimaging and neuromodulation, followed by roles at Columbia University and Baylor College of Medicine. Dr. Vanegas Arroyave mentors fellows and students, focusing on research design and execution. She is bilingual in English and Spanish, prioritizing compassionate care for diverse populations. Education: MD from Universidad de Antioquia (2005) Residencies: Neurology at North Shore-Long Island Jewish (2013–), followed by clinical-research fellowships at NIH/NINDS (2015–). Research Interests: Neuromodulation (e.g., deep brain stimulation), movement disorders, neuroimaging, and clinical trials for neurodegenerative diseases. Her work explores therapeutic efficacy, neural mechanisms, and patient outcomes. Grants/Advising: Principal Investigator for industry-sponsored trials and mentor for trainees in clinical research methodologies. Active in translational research linking neurophysiology to treatment development. Labs/Teams: Leads the Neuromodulation Research program at Baylor, advancing therapies for Parkinson’s and related disorders through interdisciplinary collaboration.

• Cell differentiation
• Ergogenic effect of supplementation in sport
• Exercise and the endocannabinoid system
• +۷ مورد دیگر

Ceci Roberta is an Associate Professor in the Department of Human and Health Sports Sciences at the University of Rome "Foro Italico". Her academic work focuses on the intersection of biochemistry, exercise science, and sports medicine, with particular emphasis on cellular responses to physical activity and oxidative stress. Her research interests center around cellular and molecular responses to exercise, particularly focusing on: Cell differentiation and mechanisms of cellular differentiation Exercise and the endocannabinoid system Polyamine metabolism in muscle differentiation Cellular response to oxidative stress Role of spermine oxidase in skeletal muscle Ergogenic effects of supplementation in sport Search for new anticoagulant drugs from biodiversity Her recent research demonstrates a strong focus on the molecular mechanisms underlying exercise adaptation, particularly examining how physical activity affects redox status, gene expression, and cellular function. She has conducted both in vivo studies with human subjects and in vitro studies with muscle cells in culture. Dr. Roberta serves in several academic capacities including as a Member of the LM67 Quality Assurance Group and the L22 Review Group, demonstrating her active role in academic governance and quality assurance within her institution. She teaches several courses at the University of Rome "Foro Italico" including: Biology and Biochemistry Applied to Sport (LM68-02A) Biological adaptations of motor activity (LM67-03A) Biochemistry (L22-26) General and Human Biology and Biochemistry (L22-02) Her teaching spans across multiple degree programs including the Degree in Motor and Sports Sciences (Class L22), Master's Degree in Preventive and Adaptive Motor Activities (Class LM67), and Master's Degree in Sports Science and Technology (Class LM68).

• Clinical Exercise Physiology
• Neurology
• Neurorehabilitation
• +۳ مورد دیگر

Martin Langeskov Christensen is an Associate Professor at Aarhus University's Department of Clinical Medicine, Neurology. His research focuses on the application of exercise interventions in neurorehabilitation, particularly for Parkinson's disease and multiple sclerosis patients. He investigates how physical activity impacts neurological outcomes, including motor function, cognitive performance, and disease progression. Research projects include exploring kynurenine pathway metabolites in multiple sclerosis patients and examining the efficacy of high-intensity aerobic exercise on brain MRI measures in neurodegenerative diseases. Current active research (2022-2025) involves PET-MRI studies assessing synaptic SV2A protein density changes in Parkinson's patients undergoing intensive exercise therapy. Key contributions include systematic reviews on aerobic capacity in Parkinson's disease, meta-analyses of muscle strength dynamics, and validation studies for exercise testing methodologies. His work bridges clinical neurology with exercise physiology to develop evidence-based rehabilitation strategies. Publications consistently demonstrate focus on translational research, aiming to turn exercise science insights into actionable clinical interventions. While no formal awards are listed, his prolific publication record (over 25 peer-reviewed articles since 2014) indicates sustained research impact in neurorehabilitation fields.

Elizabeth Akamمشاهده پروفایل

مدرس ارشد

• Genetics
• Sports Science
• Public Health
• +۴ مورد دیگر

Dr. Elizabeth Akam is a Senior Lecturer in Biosciences and a Senior Teaching Fellow within the School of Sports, Exercise and Health Sciences. Her career spans academic research, pharmaceutical industry experience, and a strong focus on sports and exercise science. She holds a BSc in Biochemistry from the University of Liverpool (awarded the Gibson Sinclair Scholarship thrice) and a PhD from the University of Leicester on muscarinic acetylcholine receptors, supported by a Wellcome Prize Scholarship. Her research interests integrate genetics with health and performance, particularly exploring genetic polymorphisms in sports, cardiovascular diseases, and cancer biology. Notable work includes studies on ACE gene polymorphisms in athletes, CAD risk in South Asian populations, and the role of exercise in modulating cancer progression. She has also contributed to advancements in mesenchymal stem cell cryopreservation and telomere dynamics in endurance athletes. Her scientific awards include the prestigious Wellcome Prize PhD Scholarship and the undergraduate Gibson Sinclair Scholarship. Research highlights include systematic reviews on combat sport genetics and menstrual cycle effects on rugby performance, alongside studies on the protective effects of endurance exercise against age-associated cancer mechanisms. Affiliations include the Lifestyle for Health and Wellbeing Research Group. Her work bridges molecular genetics, sports science, and clinical applications, addressing both fundamental and applied health questions through interdisciplinary approaches.

• Child Psychiatry
• ADHD Research
• Pediatric Behavioral Health
• +۳ مورد دیگر

Eeva Aronen is a Professor at the University of Helsinki, affiliated with the Faculty of Medicine and serving as part of the Children's Hospital research group. Her work focuses on child psychiatry, particularly ADHD, behavioral disorders, and psychopharmacology. She leads studies on medication trends, parenting interventions, and innovative assessment tools like virtual reality tasks for evaluating executive functions and goal-directed behavior. Her research integrates clinical practice with population-level analyses, including nationwide register studies on medication use and public health impacts. Key areas of expertise include pediatric mental health, developmental psychopathology, and evidence-based interventions. She supervises doctoral candidates in the Brain & Mind and Clinical Research programs, contributing to interdisciplinary training in child clinical research. Her recent projects explore victimization effects, sleep disturbances in psychiatric patients, and the longitudinal trajectories of executive function deficits. Dr. Aronen collaborates across departments and institutions, bridging basic neuroscience with clinical applications. Her team develops novel diagnostic tools (e.g., the Epeli VR task) and evaluates interventions targeting families in child protection systems. Despite no explicitly listed awards, her extensive publication record reflects leadership in advancing pediatric psychiatric care and research methodologies.

Robert Oakesمشاهده پروفایل

استادیار

• Immunology
• Biomedical Engineering
• Cell & Tissue Engineering
• +۷ مورد دیگر

Dr. Robert “Smitty” Oakes is an Assistant Professor in the Department of Biomedical Engineering at the University of Delaware, with a joint appointment as a Career Development Awardee (CDA-2) at the Department of Veterans Affairs. His research focuses on immunoengineering, leveraging nanotechnology and biomaterials to control innate immunity for applications in autoimmunity, cancer, and implantable medical devices. He holds a Ph.D. in Bioengineering from the University of Utah, with postdoctoral training at the University of Michigan (focusing on cancer metastasis) and the University of Maryland (specializing in autoimmunity therapies). His expertise spans Cell & Tissue Engineering , Drug Delivery & Nanomedicine , and Biomaterials . Key research areas include designing immunotherapies that target innate immunity to combat autoimmune diseases and cancer metastasis, as well as developing implantable systems for monitoring disease progression. His lab’s innovations include engineered niches for metastasis detection and biomaterial platforms for antigen-specific immune tolerance. Scientific Achievements: Dr. Oakes has authored 26 publications in top journals like ACS Nano and Nature Communications , secured NIH and VA funding, and received the 2023 BioInterfaces Rising Star Award. His work bridges engineering principles with immunology to address unmet clinical needs, such as improving vaccine efficacy and reducing adverse immune responses to medical implants. His research also emphasizes translational applications, including implantable diagnostics for cancer and pre-metastatic niche mimics to study tumor behavior. Collaborations span academia and industry, with a focus on advancing personalized medicine and regenerative therapies.

William B. Farquharمشاهده پروفایل

استاد

• Cardiovascular Physiology
• Hypertension
• Dietary Sodium Impact
• +۳ مورد دیگر

William B. Farquhar is a Professor at the Department of Kinesiology & Applied Physiology within the College of Health Sciences at the University of Delaware. He serves as Director of the Cardiovascular Physiology Research Lab, focusing on blood pressure regulation, hypertension, and dietary/exercise interventions. His academic career spans Harvard Medical School (instructor) and UD, where he was promoted to Associate Professor (2008) and Professor (2014). Ph.D. in Exercise and Sports Science/Exercise Physiology, Pennsylvania State University M.S. in Cardiac Rehabilitation & Exercise Science, East Stroudsburg University BS in Exercise Physiology, East Stroudsburg University Post-Doc in Integrative Physiology, Beth Israel Deaconess Medical Center His research bridges cardiovascular physiology, dietary sodium interactions, and exercise adaptation, with over 100 publications in top journals. He explores sodium's effects on blood pressure, endothelial function, and brain vascular mechanisms in diverse populations including healthy individuals, older adults, and hypertensive patients. Scientific leadership includes being a Fellow of the National Academy of Kinesiology and the American College of Sports Medicine (ACSM), where he served as Vice-President. He co-chaired ACSM's World Congress on Basic Science of Exercise and Vascular Health and served on multiple NIH and national advisory boards. National Institutes of Health (NIH) funding for 20+ years Director, Cardiovascular Physiology Research Lab Interim Provost and former Associate Dean of Research at UD Expanded departmental research/teaching infrastructure

Xin-Lin Gaoمشاهده پروفایل

استاد

• Solid and Structural Mechanics
• Multiscale Modeling
• Micro- and Nano-Mechanics
• +۵ مورد دیگر

Dr. Xin-Lin Gao is a tenured full professor of mechanical engineering at Southern Methodist University (SMU), affiliated with the Lyle School of Engineering. He has held faculty positions at the University of Texas-Dallas, Texas A&M University, and Michigan Technological University. His expertise spans solid mechanics, multiscale modeling, metamaterials, and biomechanics. He has authored over 160 journal papers, 3 book chapters, and serves as an associate editor for multiple journals, including Mechanics of Materials and CMES-Computer Modeling in Engineering & Sciences . Dr. Gao's research focuses on advanced materials and structures, including micro- and nano-mechanics, additive manufacturing, and impact mechanics. He has pioneered work on metamaterials with unique properties like negative Poisson’s ratios and customizable thermal responses. His contributions also extend to computational models for traumatic brain injury and helmet design. Education: Ph.D. Mechanical Engineering (with a minor in Mathematics), University of Wisconsin-Madison (1998) Editorial Roles: Associate editor for 3+ journals, editorial board member for 7+ journals His professional service includes leadership roles in ASME, such as Chair of the Aerospace Division and Structures & Materials Technical Committee. He has received the Gerald J. Ford Research Fellowship (2021) and was elected an ASME Fellow (2010). Dr. Gao’s work integrates theoretical, computational, and experimental methods to address challenges in materials science, structural engineering, and biomedical applications.

Abdelrahman Y. Foudaمشاهده پروفایل

استادیار

• Neuroscience
• Ophthalmology
• Immunology
• +۵ مورد دیگر

Abdelrahman Y. Fouda is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He leads the Fouda Lab, which focuses on central nervous system (CNS) injury mechanisms, particularly in the retina and brain. His research employs molecular, cellular, and animal models to study diseases like diabetic retinopathy, traumatic optic neuropathy, and stroke. Key areas include myeloid cell modulation (macrophages/microglia) and neurovascular repair. Dr. Fouda’s lab is funded by NIH/NEI and has access to advanced retinal imaging and electrophysiology equipment. Education: B.Pharm, Cairo University School of Pharmacy (2002-2007) Ph.D., University of Georgia Clinical and Experimental Therapeutics (2011-2015) Postdoctoral training at University of Georgia (2015-2016) and Augusta University (2016-2021) Research interests emphasize immune cell interactions in CNS diseases, targeting arginase pathways and HDAC3 to promote reparative phenotypes. Recent grants include the UAMS Hornick Stroke Award (2024-2025) and NIH R00 EY029373 (2021-2024). His lab’s innovations include pegylated arginase 1 therapies and proteomic analysis for retinal injury biomarkers. Key Awards: AHA Postdoctoral Fellowship (2018-2020) NIH K99/R00 Pathway to Independence Award Labs/Teams: Fouda Lab Group with specialized equipment for in vivo retinal imaging (Bioptigen SDOIS) and electroretinography (Celeris ERG). Dr. Fouda’s work bridges bench-to-bedside translational research, aiming to develop therapies for retinal and CNS injuries through precise molecular targeting.

Fang Zhengمشاهده پروفایل

دانشیار

• Neurological Diseases
• Glutamate Receptors
• Excitotoxicity
• +۷ مورد دیگر

Fang Zheng is an Associate Professor at the University of Arkansas for Medical Sciences (UAMS) College of Medicine, Department of Pharmacology and Toxicology. His research focuses on glutamate receptors and their roles in neurological diseases such as epilepsy, stroke, Alzheimer’s disease, and schizophrenia. Using molecular, biochemical, and electrophysiological techniques, his lab investigates mechanisms of excitotoxicity, neurodegeneration, and calcium signaling. Education: Ph.D. from University of Texas Medical Branch at Galveston (1994) His NIH-funded work includes studies on zinc-dependent desensitization of NMDA receptors and canonical transient receptor potential (TRPC) channels in epilepsy. Recent publications highlight TRPC3/6/7 channels as therapeutic targets and their roles in seizure pathophysiology, neurovascular coupling, and hypertension. He has contributed to understanding TRPC channel heteromerization and pharmacology in excitotoxicity. While no scientific awards are listed, his research has been supported by NIH/NINDS grants (R01 NS039418, R01 NS058503). His work spans from 1991 to 2024, emphasizing molecular determinants of receptor function and neuroprotective strategies.